Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. The Procter & Gamble Manufacturing Company
EIR
•The Procter & Gamble Manufacturing Company•August 15, 2016

The Procter & Gamble Manufacturing Company – FDA EIR, Aug 15, 2016

Record Details

The Procter & Gamble Company's Phoenix, AZ facility underwent an unannounced cGMP drug performance goal inspection by the FDA from August 11 to August 15, 2016. The inspection, conducted under the regulatory framework of CPG 7356.002 (Drug Manufacturing Inspections) and subject to the Food, Drug, and Cosmetic Act, including 21 CFR Part 210 and 211, focused on the manufacturing of over-the-counter (OTC) psyllium fiber powder. Inspectors reviewed various operational areas, including manufacturing, packaging, quality systems (annual product review, deviations, change control), material handling, supplier qualification, and laboratory systems. Notable aspects included the firm's reacquisition by P&G in 2014, the ongoing construction of new warehouse space, and the recent installation and validation of a new water generation system and air dryers. Crucially, at the conclusion of this comprehensive inspection, no significant Current Good Manufacturing Practice (cGMP) deficiencies were identified. Consequently, the FDA did not issue an FDA-483, indicating no formal violations were observed. No samples were collected, and no refusals were encountered. The closeout meeting reinforced the expectation for the company to continuously adhere to regulatory compliance.

Company
The Procter & Gamble Manufacturing Company
Inspection date
August 15, 2016
Product type
drugs
Office
Los Angeles District Office
People
  • Nicholas L. Hunt (Senior CSO, Investigator)
  • Janeen Lyle (company_representative)
  • Dan Sullivan (company_representative)
  • Lindsey Chapman (company_representative)
  • Aron J. Kolosik (recipient)
View Company Profile

ID · 1064e106-831e-4b1f-98a1-1255d1f83caf

Violation Codes3
21 CFR 21121 CFR 21021 CFR 820.50

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore The Procter & Gamble Manufacturing Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.